GBI Research, Dec 2011, Pages: 103
Research’s team of industry experts.
Rising Costs of Drug Development and a Decrease in R&D Output have Resulted in the Outsourcing of ClinicalTrials to Poland
GBI Research suggests that over the years
Business Insights, Jan 2010, Pages: 250
Central and Eastern European countries
Russia
Czech Republic
Poland
Hungary
Fees for assessment of clinicaltrial applications by research ethics committees in the principal Latin American countries
Global Industry Analysts, Inc., Oct 2008, Pages: 455
Research Development Experts (Poland)
Clinical Solutions International, LLC (USA)
Clinical Supplies Management, Inc (USA)
ClinInvent Research Pvt, Ltd (India)
CliniRX Research (India)
Clinitria Limited
Decision Resources, Inc., June 2011
markets we analyze are Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Hungary, Kosovo, Latvia, Lithuania, Former Yugoslav Republic of Macedonia, Montenegro, Poland, Romania, Serbia, Slovakia
Global Industry Analysts, Inc., Aug 2011, Pages: 188
. Further, lack of efficacy has led companies to abandon or discontinue several late-stage clinical programs. Several trials pertaining to potential drugs have failed in their objective to improve patient
Business Monitor International, Aug 2010, Pages: 85
, Synexus, a UK-based clinicaltrials company, was reported to be expanding its presence in Poland with a new research centre in the northern city of Gdynia.
This adds to the company's portfolio
PMR Ltd, Aug 2009, Pages: 85
Biotechnological Innovations in the Pharmaceutical Industry in Poland 2009: Developmentforecasts for biotechnology sector for 2009-2011
Biotechnological innovations in the pharmaceutical industry
PMR Ltd, Aug 2009, Pages: 85
Biotechnological Innovations in the Pharmaceutical Industry in Poland 2009: Developmentforecasts for biotechnology sector for 2009-2011
Biotechnological innovations in the pharmaceutical industry
Global Industry Analysts, Inc., Oct 2010, Pages: 565
Clinipace to Conduct Phase II
ClinicalTrials 103
Regeneron and Bayer to Extend Global Development Collaboration 104
Sucampo
Biophoenix Limited, July 2009, Pages: 275
market for biologics, and conservatism among prescribers. If readily available, and supported by adequate clinicaltrial data, biosimilars should appeal to third-party payers because of their lower cost, but even
Global Industry Analysts, Inc., Oct 2006, Pages: 699
Hemispherx Biopharma Initiates Alferon LDO ClinicalTrials II-85
Bristol-Myers and Merck Provide IPM with License to Develop
HIV Vaccines II-85
Hi-Tech’s Acyclovir Oral Suspension Secures FDA Approval II-85
Frost & Sullivan, Jan 2005
are immense, with this region poised for significant economic growth and housing over one third of the world’s population. Compared to other emerging markets such as Brazil, Mexico, Russia and Poland
Frost & Sullivan, June 2006
and set it on course for economic growth. Following these developments, Poland witnessed an increase in the imports and exports of the pharmaceutical products, with the over-the-counter (OTC) segment being
Business Monitor International, March 2009, Pages: 76
population makes it a relatively attractive location to conduct clinicaltrials. While the country lags behind locations such as Czech Republic, Hungary, Poland and Russia, 115 phase II to IV clinicaltrials
Business Monitor International, Jan 2012, Pages: 73
Poland Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies
Business Monitor International, Nov 2010, Pages: 56
– Market Summary
Regulatory Regime
Intellectual Property Regime
Pricing Regime
Reimbursement Regime
Industry Trends And Developments
Epidemiology
Healthcare System
ClinicalTrials Sector
Medical Devices
